Which hedge funds own NBIX? NEUROCRINE BIOSCIENCES INC, Q2 2026 13F holders
48 tracked hedge funds disclosed a position in NBIX (NEUROCRINE BIOSCIENCES INC) in their Q2 2026 13F filings, worth $2.4bn in total. The largest holder by portfolio weight is Sarissa Capital Management LP at 11.0% of its book. 14 opened a new position this quarter: Science & Technology Partners, L.P., Tobam, Diametric Capital, LP, Landscape Capital Management, L.L.C.. 18 exited: Defilade Capital Management, L.P., Parkman Healthcare Partners LLC, Ground Swell Capital, LLC.
- 48
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 14
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 18
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $32.9m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $180m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $2.4bn
- Combined value Sum of the holders' reported positions in the security.
- 3.9%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Defilade Capital Management, L.P. | 3.9% | $27.7m |
| Parkman Healthcare Partners LLC | 1.4% | $13.1m |
| Ground Swell Capital, LLC | 1.0% | $496k |
| Deerfield Management Company, L.P. | 0.9% | $80.4m |
| EntryPoint Capital, LLC | 0.3% | $883k |
| PDT Partners, LLC | 0.2% | $3.8m |
| MQS Management LLC | 0.2% | $326k |
| Edgestream Partners, L.P. | 0.2% | $6.7m |
| Trexquant Investment LP | 0.2% | $24.1m |
| Perceptive Advisors LLC | 0.2% | $8.6m |
| AlphaGrep UK Ltd | 0.2% | $560k |
| Fox Run Management, L.L.C. | 0.1% | $746k |
| Schonfeld Strategic Advisors LLC | 0.06% | $7.5m |
| Gsa Capital Partners LLP | 0.05% | $881k |
| Voleon Capital Management LP | 0.02% | $1.0m |
| ADAR1 Capital Management, LLC | 0.02% | $329k |
| Brevan Howard Capital Management LP | 0.01% | $1.4m |
| Freestone Grove Partners LP | 0.01% | $1.6m |
Ownership over time
Who discovered NBIX first? Beta
The run: Q2 2014 → Q3 2018, +729%
| Cormorant Asset Management, LP | Q2 2014 | 1.2% | +7.2 pts |
| Great Point Partners LLC high conviction | Q1 2014 | 10.2% | +5.5 pts |
| Rock Springs Capital Management LP | Q1 2014 | 0.8% | +5.0 pts |
| DAFNA Capital Management LLC | Q3 2014 | – | +4.5 pts |
| Orbimed Advisors LLC | Q1 2014 | 0.8% | +3.2 pts |
| RA Capital Management, L.P. high conviction | Q1 2014 | 0.1% | −1.1 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.